David Aronoff
-
Target trials support drug safety in pregnant patients
A new paper proposes an ethical way to test drug safety during pregnancy by using electronic health data to conduct "virtual" drug trials. Read MoreMay 28, 2020
-
Treating C. diff: new purpose for an old drug?
An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice. Read MoreSep 24, 2019
-
Pain relievers a risk for C. diff?
David Aronoff and colleagues report an increased risk of the serious gastrointestinal infection C. diff following the use of NSAID pain relievers. Read MoreJan 17, 2019
-
VUMC drug repurposing initiative gaining momentum
Drug repurposing involves establishing an additional approved indication for a drug already at market. Read MoreApr 19, 2018
-
Grant bolsters study of potential new therapy for C. diff infection
According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis. Read MoreMar 22, 2018
-
Aronoff elected to microbiology academy
Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology. Read MoreApr 27, 2017
-
Aronoff to lead Division of Infectious Diseases
David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases. Read MoreNov 14, 2013